Luis Soler Ranzani,Albert Falivene Aldea,Gemma Casadevall Pujals
申请号：
US14388308
公开号：
US20150164920A1
申请日:
2013.03.27
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention refers to a controlled release pharmaceutical formulation in solid form comprising Mesalamine. The invention also contemplates the preparation of the said formulation and its use for the treatment of patients suffering from inflammatory bowel disease (IBD).
